Search Results - "Bizien, L"
-
1
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Published in Science (American Association for the Advancement of Science) (23-10-2020)“…Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least…”
Get full text
Journal Article -
2
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Published in Science (American Association for the Advancement of Science) (23-10-2020)“…Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease…”
Get full text
Journal Article -
3
Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Published in The Journal of experimental medicine (05-07-2021)“…Patients with biallelic loss-of-function variants of AIRE suffer from autoimmune polyendocrine syndrome type-1 (APS-1) and produce a broad range of…”
Get full text
Journal Article -
4
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Published in Proceedings of the National Academy of Sciences - PNAS (24-05-2022)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) doubles with every 5 y of age from childhood onward. Circulating…”
Get full text
Journal Article -
5
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children
Published in Science (American Association for the Advancement of Science) (10-02-2023)“…Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that follows benign COVID-19. We report autosomal recessive deficiencies…”
Get full text
Journal Article -
6
Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths
Published in Science immunology (19-08-2021)“…Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of…”
Get more information
Journal Article -
7
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Published in The Journal of experimental medicine (07-11-2022)“…Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19 pneumonia and yellow fever vaccine disease. We report here on 13 patients…”
Get full text
Journal Article -
8
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Published in Nature (London) (23-11-2023)“…Patients with autoimmune polyendocrinopathy syndrome type 1 (APS-1) caused by autosomal recessive AIRE deficiency produce autoantibodies that neutralize type I…”
Get full text
Journal Article -
9
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Published in The Journal of experimental medicine (05-02-2024)“…We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-α2 in 10…”
Get full text
Journal Article -
10
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Published in The Journal of experimental medicine (04-07-2022)“…Autosomal recessive IRF7 deficiency was previously reported in three patients with single critical influenza or COVID-19 pneumonia episodes. The patients'…”
Get full text
Journal Article -
11
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Published in The Journal of experimental medicine (04-11-2024)“…Human inborn errors of thymic T cell tolerance underlie the production of autoantibodies (auto-Abs) neutralizing type I IFNs, which predispose to severe viral…”
Get more information
Journal Article -
12
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Published in Genome medicine (05-04-2023)“…We previously reported that impaired type I IFN activity, due to inborn errors of TLR3- and TLR7-dependent type I interferon (IFN) immunity or to…”
Get full text
Journal Article -
13
Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB115:02 or 16:02 individuals
Published in The Journal of clinical investigation (2024)“…BACKGROUNDWeakly virulent environmental mycobacteria (EM) can cause severe disease in HLA-DRB1*15:02 or 16:02 adults harboring neutralizing anti-IFN-γ…”
Get full text
Journal Article -
14
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency
Published in The Journal of experimental medicine (2024)“…Inherited deficiency of the RNA lariat-debranching enzyme 1 (DBR1) is a rare etiology of brainstem viral encephalitis. The cellular basis of disease and the…”
Get full text
Journal Article -
15
Autoantibodies against type I IFNs in humans with alternative NF-.B pathway deficiency
Published in Nature (London) (2023)Get full text
Journal Article -
16
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Published in Annals of intensive care (31-12-2022)“…Background Auto-antibodies (auto-Abs) neutralizing type I interferons (IFN) have been found in about 15% of critical cases COVID-19 pneumonia and less than 1%…”
Get full text
Journal Article -
17
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Published in Genome medicine (06-01-2024)Get full text
Journal Article -
18
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies
Published in Frontiers in cellular and infection microbiology (14-01-2022)“…Abstract SARS-CoV-2 infection fatality rate (IFR) doubles with every five years of age from childhood onward. Circulating autoantibodies neutralizing IFN-α,…”
Get full text
Journal Article -
19
Le déficit en interféron de type I n’altère pas la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après vaccination par ARNm
Published in La revue de medecine interne (01-06-2022)“…Les vaccins à ARN messagers ont joué un rôle majeur dans la lutte contre la pandémie de SARS-CoV-2 grâce à une excellente efficacité et sécurité clinique. Ces…”
Get full text
Journal Article